Stay updated on Cenobamate Open-Label Extension Study Clinical Trial
Sign up to get notified when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.

Latest updates to the Cenobamate Open-Label Extension Study Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov record for the completed cenobamate extension study is displayed, with details including its design, eligibility criteria, locations, and outcomes.SummaryDifference58%

- Check8 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study content, replacing the previous details and navigation and making the record inaccessible until the issue is resolved.SummaryDifference17%

- Check57 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous v3.6.6, indicating a software release or patch. This update does not modify the study details or other substantive content.SummaryDifference0.0%

Stay in the know with updates to Cenobamate Open-Label Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.